[Treatment of hematologic diseases with alpha interferon].
Since 1970, several trials conducted with natural alpha interferon have allowed the recognition of sensitive disorders to this new type of treatment. These studies are ongoing now with recombinant alpha interferons in hairy cell leukaemia, low grade lymphomas, myeloproliferative disorders and myeloma.
Castaigne
S
S
Département d'hématologie clinique, Hôpital Saint-Louis, Paris, France.
D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D007943:Leukemia, Hairy Cell / Q000628:therapy*; D008223:Lymphoma / Q000628:therapy*; D009101:Multiple Myeloma / Q000628:therapy*; D009196:Myeloproliferative Disorders / Q000628:therapy*
D007370:Interferon Type I
Traitement des maladies hématologiques par l'interféron alpha.